Paul Tudor Jones Biogen Inc. Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Biogen Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 45,042 shares of BIIB stock, worth $10.1 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
45,042
Previous 3,900
1054.92%
Holding current value
$10.1 Million
Previous $1.01 Million
862.54%
% of portfolio
0.06%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding BIIB
# of Institutions
1,046Shares Held
126MCall Options Held
1.37MPut Options Held
1.35M-
Vanguard Group Inc Valley Forge, PA16.6MShares$3.73 Billion0.07% of portfolio
-
Primecap Management CO Pasadena, CA16.2MShares$3.65 Billion2.65% of portfolio
-
Black Rock Inc. New York, NY14.1MShares$3.18 Billion0.07% of portfolio
-
State Street Corp Boston, MA6.75MShares$1.52 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.17MShares$1.16 Billion0.68% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $32.4B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...